Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
ACS Nano|October 12, 2023
Highly Active Myeloid Therapy for CancerIna R Fredrich, Elias A Halabi, Rainer H Kohler, et al.JCI Insight|October 5, 2016
Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammationHsing-Chuan Tsai, Yingxiang Huang, Christopher S Garris, et al.Theranostics|May 22, 2024
A non-lipid nucleic acid delivery vector with dendritic cell tropism and stimulationHyung Shik Kim, Elias A Halabi, Noah Enbergs, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 11, 2024
Pharmacological Polarization of Tumor-Associated Macrophages Toward a CXCL9 Antitumor PhenotypeNoah Enbergs, Elias A Halabi, Anne-Gaëlle Goubet, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 9, 2023
Hybrid LNP Prime Dendritic Cells for Nucleotide DeliveryRiddha Das, Elias A Halabi, Ina R Fredrich, et al.Nature Biomedical Engineering|April 25, 2019
TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapyChristopher B Rodell, Sean P Arlauckas, Michael F Cuccarese, et al.ACS Nano|October 8, 2025
A Myeloid Cell-Targeted Immunostimulant Cocktail (MyTai) Enhances Cancer ImmunotherapyHyung Shik Kim, Grant G Simpson, Jasmine Carrothers, et al.Nature Biomedical Engineering|October 22, 2025
Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrenceYannik Kaiser, Christopher S Garris, Eliana Marinari, et al.Advanced Materials (Deerfield Beach, Fla.)|November 25, 2022
Dual Immunostimulatory Pathway Agonism through a Synthetic Nanocarrier Triggers Robust Anti-Tumor Immunity in Murine GlioblastomaSophie Lugani, Elias A Halabi, Juhyun Oh, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 6, 2024
Targeted SPP1 Inhibition of Tumor-Associated Myeloid Cells Effectively Decreases Tumor SizesBenan Kartal, Christopher S Garris, Hyung Shik Kim, et al.Pageof 3